Healthcare Provider Thomson Medical Reports Net Loss for First Half of 2025 Fiscal Year
Thomson Medical, a healthcare provider, has reported a net loss of S$12.9 million for the first half of its 2025 fiscal year, a reversal of its net profit of S$2 million for the corresponding period in the year before.
Challenges in Malaysia Market
The losses came mainly from challenges in the Malaysia market, increased interest expenses following the acquisition of Far East Medical Vietnam, and the cessation of non-core transitional care facilities projects in Singapore, according to the company in a bourse filing on Wednesday.
Revenue Increase
Despite the losses, revenue actually rose by 18.4% to S$199.1 million from S$168.1 million over the same period. The increase was attributed mainly to revenue contribution from Vietnam, following the acquisition of Far East Medical Vietnam in December 2023.
Uncertain Outlook
Thomson Medical said that the overall economic outlook remains uncertain, clouded by inflation, rising geopolitical tensions, and uncertainty over the US’ trade policy. The company also faces challenges in Singapore’s healthcare sector, which is expected to remain competitive with cost pressures and market maturity.
Regional Growth
Regionally, Malaysia and Vietnam’s healthcare sectors are poised for growth, driven by a growing middle class, changing lifestyles, and an ageing population, as well as their increasing popularity as medical-tourism destinations.
Company’s Strategy
Thomson Medical is well-placed to adapt to the unique conditions in each country and leverage opportunities to position itself for long-term growth. In Singapore, the company is poised to increase footfall and bed occupancy when Thomson Medical Centre completes its renovation. In Malaysia, the hospital in Damansara will grow its bed count from 373 to 554 and expand its specialties and services to drive higher patient load and larger treatment scopes.
Conclusion
Thomson Medical’s financial performance in the first half of its 2025 fiscal year was impacted by challenges in the Malaysia market, increased interest expenses, and the cessation of non-core transitional care facilities projects in Singapore. Despite these challenges, the company remains confident in its ability to adapt to the unique conditions in each country and leverage opportunities to position itself for long-term growth.
FAQs
Q: What were the main reasons for Thomson Medical’s net loss?
A: Challenges in the Malaysia market, increased interest expenses following the acquisition of Far East Medical Vietnam, and the cessation of non-core transitional care facilities projects in Singapore.
Q: What was the revenue increase for the first half of 2025 fiscal year?
A: 18.4% to S$199.1 million from S$168.1 million.
Q: What are the company’s plans to grow its business in Singapore and Malaysia?
A: In Singapore, Thomson Medical will increase footfall and bed occupancy when Thomson Medical Centre completes its renovation. In Malaysia, the hospital in Damansara will grow its bed count and expand its specialties and services to drive higher patient load and larger treatment scopes.
Q: What are the company’s plans to grow its business in Vietnam?
A: Thomson Medical will enhance its specialist services and add a new wing to increase floor space. It also aims to capture the growing segment of medical tourists from Cambodia, Laos, Myanmar, and China to Vietnam.
